Mediaboss Marketing

This research report on the Global Quantum Computing for Enterprise Market provides an in-depth analysis of the market share, industry size, and current and future market trends. The Quantum Computing for Enterprise market report majorly sheds light on the market scope, growth prospects, potential, and the historical data of the market. TheQuantum Computing for Enterprise market report offers a complete segmentation depending on the factors such as end-use, type, application, and geographical regions that offer the assessment of every aspect of the Quantum Computing for Enterprise market. Similarly, the Quantum Computing for Enterprise report contains the market share on the basis of current as well as forecasted Quantum Computing for Enterprise market growth.

This study covers following key players:1QB Information TechnologiesAirbusAnyon SystemsCambridge Quantum ComputingD-Wave SystemsGoogleMicrosoftIBMIntelQC WareQuantumRigetti ComputingStrangeworksZapata Computing

Request a sample of this report @ https://www.orbismarketreports.com/sample-request/66126?utm_source=Puja

Furthermore, the Quantum Computing for Enterprise market broadly analyzes accurate estimations of the Quantum Computing for Enterprise market. Thisglobal market report also examines the market segments, ascendant contenders,competitive analysis, industry environment, and modern trends of the global Quantum Computing for Enterprise market. Thus, such factors are majorly considered the progress assessment of the Quantum Computing for Enterprise market. In addition, the Quantum Computing for Enterprise market study delivers a deepestimate of the global industrydemand, market share, and sales, industry revenue, and market size of the target industry.

Access Complete Report @ https://www.orbismarketreports.com/global-quantum-computing-for-enterprise-market-size-status-and-forecast-2019-2025-2?utm_source=Puja

Market segment by Type, the product can be split into HardwareSoftware

Market segment by Application, split into BFSITelecommunications and ITRetail and E-CommerceGovernment and DefenseHealthcareManufacturingEnergy and UtilitiesConstruction and EngineeringOthers

Moreover, the retailers, exporters, and the leading service providers over the globe are also provided in the Quantum Computing for Enterprise market report along with their data such as price, product capacity, company profile, product portfolio, market revenue, and the cost of the product. Likewise, the graphical description and suitable figures of the Quantum Computing for Enterprise industry are also featured in this report. This research report also gives data like sales revenue, industry value & volume, upstream & downstream buyers, and industry chain formation. Likewise, the Quantum Computing for Enterprise market study offers an extensiveview of the changing market dynamics, market trends, restraints, driving factors, changing patterns, as well as restrictions of the market. The Quantum Computing for Enterprise market study is designed through quantitative and qualitative research techniques that majorly shed light on the industry growth and various challenges facing by the leading competitors along with the gap analysis and beneficial opportunities provided by the Quantum Computing for Enterprise market.

Some Major TOC Points:1 Report Overview2 Global Growth Trends3 Market Share by Key Players4 Breakdown Data by Type and ApplicationContinued

The Quantum Computing for Enterprise research study is a helpful analysis which emphasizing on geographical analysis, primary & secondary research methodologies, market drivers, and leading segmentation and sub-segments analysis. With the whole overview of the Quantum Computing for Enterprise market, the studyprovides the overall viability of future projects and delivers the Quantum Computing for Enterprise report conclusion. The Quantum Computing for Enterprise market report also delivers market evaluationalong with the PESTEL, SWOT, and other necessary data. In addition, the Quantum Computing for Enterprise market study categorizes the global market data by using numerous factors such as application, region, manufacturers, and type.

For Enquiry before buying report @ https://www.orbismarketreports.com/enquiry-before-buying/66126?utm_source=Puja

About Us : With unfailing market gauging skills, has been excelling in curating tailored business intelligence data across industry verticals. Constantly thriving to expand our skill development, our strength lies in dedicated intellectuals with dynamic problem solving intent, ever willing to mold boundaries to scale heights in market interpretation.

Contact Us : Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

Here is the original post:
Global Quantum Computing for Enterprise Market Expected to Reach Highest CAGR by 2025 Top Players: 1QB Information Technologies, Airbus, Anyon...

Quantum teleportation is an important step in improving quantum computing.

Beam me up is one of the most famous catchphrases from the Star Trek series. It is the command issued when a character wishes to teleport from a remote location back to the Starship Enterprise.

While human teleportation exists only in science fiction, teleportation is possible in the subatomic world of quantum mechanicsalbeit not in the way typically depicted on TV. In the quantum world, teleportation involves the transportation of information, rather than the transportation of matter.

Last year scientists confirmed that information could be passed between photons on computer chips even when the photons were not physically linked.

Now, according to new research from the University of Rochester and Purdue University, teleportation may also be possible between electrons.

A quantum processor semiconductor chip is connected to a circuit board in the lab of John Nichol, an assistant professor of physics at the University of Rochester. Nichol and Andrew Jordan, a professor of physics, are exploring new ways of creating quantum-mechanical interactions between distant electrons, promising major advances in quantum computing. Credit: University of Rochester photo / J. Adam Fenster

In a paper published in Nature Communications and one to appear in Physical Review X, the researchers, including John Nichol, an assistant professor of physics at Rochester, and Andrew Jordan, a professor of physics at Rochester, explore new ways of creating quantum-mechanical interactions between distant electrons. The research is an important step in improving quantum computing, which, in turn, has the potential to revolutionize technology, medicine, and science by providing faster and more efficient processors and sensors.

Quantum teleportation is a demonstration of what Albert Einstein famously called spooky action at a distancealso known as quantum entanglement. In entanglementone of the basic of concepts of quantum physicsthe properties of one particle affect the properties of another, even when the particles are separated by a large distance. Quantum teleportation involves two distant, entangled particles in which the state of a third particle instantly teleports its state to the two entangled particles.

Quantum teleportation is an important means for transmitting information in quantum computing. While a typical computer consists of billions of transistors, called bits, quantum computers encode information in quantum bits, or qubits. A bit has a single binary value, which can be either 0 or 1, but qubits can be both 0 and 1 at the same time. The ability for individual qubits to simultaneously occupy multiple states underlies the great potential power of quantum computers.

Scientists have recently demonstrated quantum teleportation by using electromagnetic photons to create remotely entangled pairs of qubits.

Qubits made from individual electrons, however, are also promising for transmitting information in semiconductors.

Individual electrons are promising qubits because they interact very easily with each other, and individual electron qubits in semiconductors are also scalable, Nichol says. Reliably creating long-distance interactions between electrons is essential for quantum computing.

Creating entangled pairs of electron qubits that span long distances, which is required for teleportation, has proved challenging, though: while photons naturally propagate over long distances, electrons usually are confined to one place.

In order to demonstrate quantum teleportation using electrons, the researchers harnessed a recently developed technique based on the principles of Heisenberg exchange coupling. An individual electron is like a bar magnet with a north pole and a south pole that can point either up or down. The direction of the polewhether the north pole is pointing up or down, for instanceis known as the electrons magnetic moment or quantum spin state. If certain kinds of particles have the same magnetic moment, they cannot be in the same place at the same time. That is, two electrons in the same quantum state cannot sit on top of each other. If they did, their states would swap back and forth in time.

The researchers used the technique to distribute entangled pairs of electrons and teleport their spin states.

We provide evidence for entanglement swapping, in which we create entanglement between two electrons even though the particles never interact, and quantum gate teleportation, a potentially useful technique for quantum computing using teleportation, Nichol says. Our work shows that this can be done even without photons.

The results pave the way for future research on quantum teleportation involving spin states of all matter, not just photons, and provide more evidence for the surprisingly useful capabilities of individual electrons in qubit semiconductors.

References:

Conditional teleportation of quantum-dot spin states by Haifeng Qiao, Yadav P. Kandel, Sreenath K. Manikandan, Andrew N. Jordan, Saeed Fallahi, Geoffrey C. Gardner, Michael J. Manfra and John M. Nichol, 15 June 2020, Nature Communications.DOI: 10.1038/s41467-020-16745-0

Coherent multi-spin exchange in a quantum-dot spin chain by Haifeng Qiao, Yadav P. Kandel, Kuangyin Deng, Saeed Fallahi, Geoffrey C. Gardner, Michael J. Manfra, Edwin Barnes, John M. Nichol, Accepted 12 May 2020, Physical Review X.arXiv: 2001.02277

Here is the original post:
Teleportation Is Indeed Possible At Least in the Quantum World - SciTechDaily

Honeywell has announced the creation of the worlds highest-performing quantum computing system. With a quantum volume of 64, the Honeywell quantum computer is twice as powerful as the next alternative in the industry.

What makes our quantum computers so powerful is having the highest quality qubits, with the lowest error rates. This is a combination of using identical, fully connected qubits and precision control, said Tony Uttley, president of Honeywell Quantum Solutions.

The core of the Honeywell system is an ultra-high vacuum chamber, which is a stainless steel sphere, about the size of a basketball. It has portals to allow in laser light, and from which the air has been pumped out such that it contains a vacuum of five times less particles than outer space. The chamber is cryogenically cooled to the temperature slightly above absolute zero (-262.7 C).

Inside the chamber are ion traps, each of which is the size of a coin of 25 US cents (24.3 mm). The ion plays the role of a qubit, and it is controlled by a laser, which is aimed at trapping the charge from outside the sphere through a small glass window. Within the chamber, electric fields levitate individual atoms 0.1 mm above an ion trap, a silicon chip covered in gold about the size of a quarter. Scientists shine lasers at these positively charged atoms to perform quantum operations.

For the context of how small an atom is, if you cup your hands into a sphere, youre holding about a trillion trillion atoms, Tony said.

According to the company, the main focus while building the quantum computer was on eliminating the errors present within the system on smaller numbers of qubits and then working to scale up the number of qubits. Low errors in the quantum operations expand the quantum volume, ultimately increasing the capability of quantum computing.

The Honeywell quantum computer has already been tested by JPMorgan Chase, one of the largest financial institutions, which has its own quantum experts. In addition to JPMorgan Chase, other customers whose names the company does not disclose are testing the new Honeywell system. According to Honeywell, these are companies and organizations that are related to chemistry, materials science, machine learning, and optimization. Later this year, Honeywell, along with Microsoft, will provide access to the new quantum computer through the Microsoft Azure cloud.

Here is the original post:
Honeywell announces the creation of worlds highest performing quantum computer - Inceptive Mind

The camera crew was given full access to Earnest-Nobles research. In several scenes, Earnest-Noble is suited up in white PPE in the Pritzker Nanofabrication Facility in the Eckhardt Research Center. His scientific process and the breakthrough he seeks are depicted with animations and close-up footage of the state-of-the-art facilities. The filmmakers capture Earnest-Noble in the midst of a failed attempt or among his graveyard of failed quantum devices. As he embraces his doubts and is propelled by tenacity, viewers witness an emotional depiction of real science.

Earnest-Nobles lively interviews focus on the experience versus the result of his labors, providing a realistic portrayal of graduate studies and enabling viewers to follow him to his goal of identifying the ideal qubit for superpositiona phenomenon in quantum mechanics in which a particle can exist in several states at once.

When we were filming, I was trying to explain a qubit or something, and how much I was using jargon words was eye-opening to me. It helped me appreciate the challenge of making science understandable, said Earnest-Noble, who is now a quantum computing researcher at IBM. Science is a process far more than a series of facts. That became clear to me from working on this project.

Science communications typically takes a very long struggle of discovery and wraps it up into a pretty package, said Schuster. But something I found very special in this story is that you got to follow Nate for a couple of years. It accurately captured what Nates experience was like. And it focused on his experience, and not on the result, which is pretty amazing."

STAGEs director of science Sunanda Prabhu-Gaunkar originally joined the STAGE lab as a postdoc, and taught herself filmmaking in order to create the series. The scientific process inspires our filmmaking, she said. The workflow embraces failure, remains receptive to discoveries through iteration, and allows for risk-taking, all within a highly collaborative process.

Ellen Askey, the pilot episodes co-director, joined the project as a first-year student at UChicago with prior filmmaking experience. She worked on the series across her college career, graduating in June with a degree in cinema and media studies. Showing a story develop over time can be powerful, she said. We hope to get it out there to a lot of people who are and who are not yet interested in science.

Interested attendees can register through Eventbrite.

Adapted from an article by Maureen McMahon posted on the Physical Sciences Division website.

More here:
Docuseries takes viewers into the lives and labs of scientists - UChicago News

Expansion to 30 portfolio companies and 46% increase in net asset value, reinforcing CICs position as the most active series A investor in the Cambridge ecosystem

22 June 2020

Cambridge Innovation Capital plc (CIC), the venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, today announces highlights from its annual results for the year ended 31 March 2020.

Andrew Williamson, Managing Partner of CIC, commented: Despite the recent challenges posed by the global coronavirus pandemic, we have made tremendous progress during the year. Our portfolio now includes one company valued in excess of 1 billion and another that has listed on Nasdaq, our first IPO. We have expanded the number of companies in, and value of, our portfolio, enhanced our potential deal flow with the creation of two accelerators and augmented our team to support the growth of the business.

Highlights

Net assets grew by 46% to 301.7 million at 31 March 2020 (2019: 206.4 million)

35.7 million (2019: 44.9 million) invested into four new and 12 existing portfolio companies, bringing the total invested to 163.0 million in 30 companies (2019: 127.3 million in 26 companies)

A fair value increase of 69.5 million (2019: 30.7 million) which, together with investments, resulted in a portfolio value of 291.5 million (2019: 186.3 million)

42.5 million (2019: 38.6 million) drawn down from the 150 million committed by shareholders in the year ended 31 March 2019

Welcomed Riverlane, Sense Biodetection, PredictImmune and Immutrin to CICs family of portfolio companies (and PetMedix post-period)

Bicycle Therapeutics conducted its NASDAQ IPO to progress its programmes, including toxin drug conjugates and immune modulators, to treat cancer and other debilitating diseases

CMR Surgical closed a 195.0 million Series C funding round to commercialise its next generation surgical robotic system

Expanded our team with the appointment of Vin Lingathoti as a Partner in our investment team, Nick Richards as General Counsel and Michelle Lamprecht as Head of Marketing

Further details

Bicycle Therapeutics, where we participated in its Nasdaq IPO to progress the companys pipeline of Bicycle Toxin Conjugates and Immune Cell Agonists to treat cancer and other debilitating diseases. Bicycle Therapeutics is the first company in our diverse portfolio to conduct an IPO and exemplifies the way in which we support the transformation of exciting, early-stage companies from the Cambridge ecosystem as they develop into global, category-leading companies.

CMR Surgical, which closed a 195 million Series C funding round, Europes largest private financing round in the medical technology sector, to commercialise its next-generation surgical robotic system, Versius. We were an early investor in CMR Surgical, having first invested in the companys Series A round in 2016, and we have continued to provide financial support and guidance to the company, enabling the realisation of the potential of the Versius system. The proceeds will be used to drive the next stage of CMR Surgicals growth, including the planned commercialisation of its Versius system, while supporting continued research and development, manufacturing and expansion.

AudioTelligence, in which we participated in a 6.5 million Series A funding. AudioTelligence is dedicated to making speech clear and intelligible in a noisy world. While the adoption of voice-activated technologies in smart homes and workplaces is on the rise, the accuracy of modern speech recognition systems remains severely limited in noisy environments. To tackle this problem, AudioTelligences technology acts like autofocus for sound, using data-driven blind audio signal separation to focus on the source of interest, allowing it to be separated from interfering noises. This enables microphones to focus on what users are saying, improving the audio quality for listeners, regardless of background noise.

Cytora, which closed a 25 million Series B financing round, to continue developing its artificial intelligence-powered insurance technology platform that enables insurers to underwrite more accurately, reduce frictional costs and achieve profitable growth. Cytoras underwriting platform applies Machine Learning and Natural Language Processing techniques to public and proprietary data sets, including property construction features, company financials and local weather. The platform combines these data sets with an insurance companys internal data to better predict risk, thereby ensuring more accurate risk pricing.

Riverlane, a quantum computing software developer transforming the discovery of new materials and drugs. We led the 3.3 million seed round in which Cambridge Enterprise, the commercialisation arm of the University of Cambridge, also participated. Riverlanes software leverages the capabilities of quantum computers, which operate using the principles of quantum mechanics. In the same way that graphics processing units accelerate machine learning workloads, Riverlane uses quantum computers to accelerate the simulation of quantum systems. Riverlane is working with leading academics and companies on critical early use cases for its software, such as developing new battery materials and drug treatments.

Sense Biodetection, in which we co-led the 12.3 million Series A funding round alongside Earlybird, to develop a portfolio of instrument-free, point-of-care molecular diagnostic tests, a pioneering new class of diagnostic product. Sense Biodetection plans to invest the new funds in the development and manufacture of a range of tests utilising its novel and proprietary rapid molecular amplification technology, targeting in the first instance infectious disease applications such as COVID-19 and influenza. Instrument-free molecular diagnostics represent the ultimate flexible test format as the tests could be deployed in any setting and by a wide range of potential users. This has the potential to be transformational for the diagnostic industry, delivering for the first time true point-of-care testing in a market-successful, single-use product format, allowing diagnostic tests to be readily adopted by new users and scaled to meet demand.

During the year we also announced the launch of Start Codon and established DeepTech.labs, two new accelerators that are focused on accelerating the translation of world-class research into commercially successful companies. The Cambridge ecosystem has already produced over a dozen billion-pound businesses and we believe that these accelerators will be important facilitators in creating many such further successes. We are extremely proud to be founders and co-owners and we eagerly await the world-class businesses that will emerge from their programmes in the future.

Post-period Highlights

We invested in PetMedix, a Cambridge, UK-based biopharmaceutical company developing antibody-based therapeutics for companion animals and our first investment in the animal health space. PetMedix has developed an innovative platform for the creation of naturally generated, fully species-specific therapeutic antibodies, enabling the discovery of its own veterinary medicines to target some of the most important clinical areas in animal health.

Inivata, a leader in liquid biopsy, formed a strategic collaboration with NeoGenomics, Inc (NASDAQ: NEO), for the commercialisation of its InVisionFirst -Lung liquid biopsy test in the US. NeoGenomics is a leading US-based cancer diagnostics and services company, and an established player in the field with significant commercial reach and scale. NeoGenomics also made a $25 million equity investment in Inivata and an option to acquire the company outright. The new funding will be used to accelerate the companys innovative liquid biopsy products, including further development work on RaDaR, the newly launched highly sensitive personalized assay for the detection of residual disease and recurrence.

Microbiotica entered a major collaboration with Cancer Research UK and Cambridge University Hospitals NHS Foundation Trust (CUH) to identify and develop microbiome co-therapeutics and biomarkers for cancer patients receiving immune checkpoint inhibitor therapy. The collaboration is based on clinical studies conducted by CUH that evaluate immune checkpoint inhibitor drug response in cancer patients, combined with Microbioticas unrivalled microbiome profiling and analysis capability.

A consortium led by Riverlane has been awarded a 7.6 million grant from the government's Industrial Challenge Strategy Fund to deploy a highly innovative quantum operating system. The project will deliver an operating system that allows the same quantum software to run on different types of quantum computing hardware. The aim is to install Deltaflow.OS, a quantum operating system, on every quantum computer in the UK, thereby accelerating the commercialisation of the UKs quantum computing sector.

Exvastat has been awarded a 3.6 million grant from the European Commissions Innovative Medicines Initiative to fund a clinical study of Imprenti, an intravenous formulation of imatinib, in the treatment of COVID-19-associated Acute Respiratory Distress Syndrome (ARDS). Under the award, Exvastat will collaborate with Vrije Universitat Amsterdam, the Amsterdam Medical Center, KABS Pharmaceutical Services of Canada and the clinical research organisation, Simbec-Orion.

Excerpt from:
Cambridge Innovation Capital plc: Annual results for the year ended 31 March 2020 - PharmiWeb.com